Another mechanism is that immune-resistant variants of tumour cells arise because of MHC (major histocompatibility complex) I and II selection and mutations in antigen processing, which reduce their antigenicity (they reduce MHC expression and disrupt antigen presentation). The gene discussed is HLA-C; the disease is neoplasm.